N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: Role of liver transforming growth factor-beta and oxidative stress

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 8, 2009, Pages 908-914

  Galicia Moreno, Marina ^a   Rodríguez Rivera, Adriana ^a   Reyes Gordillo, Karina ^a   Segovia, José ^a   Shibayama, Mineko ^a   Tsutsumi, Victor ^a   Vergara, Paula ^a   Moreno, Mario G ^a   Muriel, Pablo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Carbon tetrachloride; Cirrhosis; Cytokines; Fibrosis; Glutathione; Lipid peroxidation; Liver damage; N acetylcysteine; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CARBON TETRACHLORIDE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLYCOGEN; HYDROXYPROLINE; PARACETAMOL; TRANSFORMING GROWTH FACTOR BETA; ANTIOXIDANT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; COLORIMETRY; CONTROLLED STUDY; DRUG MECHANISM; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER CIRRHOSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; INTOXICATION; LIVER CIRRHOSIS, EXPERIMENTAL; METABOLISM; WISTAR RAT;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CARBON TETRACHLORIDE; CARBON TETRACHLORIDE POISONING; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA;

EID: 67651027320     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32831f1f3a     Document Type: Article

References (38)

1. Wynn T. Common and unique mechanism regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007; 117:524-529. (Pubitemid 46348506)
2. Muriel P. Cytokines in liver diseases. In: Sahu S, editor. Hepatotoxicity: from genomics to in vitro and in vivo models. West Sussex UK: John Wiley and Sons Ltd.; 2007. pp. 371-389.
3. Eghbali-Fatourechi G, Sheik G, Prakash Y, Maercklein P, Groes G, Fitzpatrick L. Type I procollagen production and cell proliferation is mediated by transforming growth factor-beta in a model of hepatic fibrosis. Endocrinology 1996; 137:1894-1903. (Pubitemid 26133966)
4. Muriel P. Some experimental models of liver damage. In: Sahu S, editor. Hepatotoxicity: from genomics to in vitro and in vivo models. West Sussex UK: Wiley and Sons Ltd.; 2007. pp. 119-137.
5. Muriel P. Peroxidation of lipids and liver damage. In: Baskin SI, Salem H, editors. Antioxidants, oxidants, and free radicals. Washington DC: Taylor and Francis; 1997. pp. 237-257.
6. De Vries N, De Flora S. N-Acetyl-l-Cysteine. J Cell Biochem 1993; 17F:270-277.
7. Kobrinsky NL, Sjolander DE, Goldenberg JA, Ortmeier TC. Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith-Wiedemann syndrome with high dose acetaminophen and N-acetylcysteine rescue. Pediatr Blood Cancer 2005; 45:222-225.
8. Rodrigues AJ, Evora PR, Schaff HV. Protective effect of N-acetylcysteine against oxygen radical-mediated coronary artery injury. Braz J Med Biol Res 2004; 37:1215-1224.
9. Akgun E, Caliskan C, Celik HA, Ozutemiz AO, Tuniyurek M, Aydin HH. Effects of N-acetylcysteine treatment on oxidative stress in acetic acid-induced experimental colitis in rats. J Int Med Res 2005; 33:196-206. (Pubitemid 40372435)
10. Yagci G, Gul H, Simsek A, Buyukdogan V, Onguru O, Zeybek N, et al. Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in rats. J Gastroenterol 2004; 39:268-276. (Pubitemid 38519433)
11. Kopp J, Seyhan H, Müller B, Lanezak J, Pausch E, Gressner AM, et al. N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblast isolated from Dupuytren's disease by blunting TGF-b signaling. J Cell Mol Med 2006; 10:157-165.
12. Meurer SK, Lahme B, Tihaa L, Weiskirchen R, Gressner AM. N-acetyl-L-cysteine supresses TGF-beta signaling at distinct molecular steps: the biochemical and biological efficacy of a multifunctional, antifibrotic drug. Biochem Pharmacol 2005; 70:1026-1034. (Pubitemid 41262078)
13. Reitman S, Frankel S. A colorimetric method for determination of serum oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957; 28:56-63.
14. Bergmeyer HU, Grabl M, Walter HE. Enzymes. In: Bergmeyer J, Grabl M, editors. Methods of enzymatic analysis. Weinheim: Verlag-Chemie; 1983. pp. 269-270.
15. Glossman M, Neville DM. Glutamyl transferase in kidney brush border membranes. FEBS Lett 1972; 19:340-344.
16. Okawa H, Ohmishi N, Yagi K. Assay for lipid peroxides in animal tissues by the thiobarbituric acid reaction. Anal Biochem 1979; 95:351-358. (Pubitemid 9194347)
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72:248-254.
18. Seifter S, Dayton S, Novic B, Muntwyler E. The estimation of glycogen with the anthrone reagent. Arch Biochem 1950; 25:191-200.
19. Pérez-Severiano F, Escalante B, Vergara P, Ríos C, Segovia J. Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntingtońs disease mutation. Brain Res 2002; 951:36-42. (Pubitemid 35253894)
20. Garcia-Tovar C, Perez A, Luna J, Mena R, Osorio B, Aleman V, et al. Biochemical and histochemical analysis of 71 kDa dystrophin isoform (Dp 71f) in rat brain. Acta Histochem 2001; 103:209-224. (Pubitemid 32385679)
21. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15:290-301.
22. Lijnen PJ, Petrov VV, Fagard RH. Induction of cardiac fibrosis by transforming growth factor-b1. Mol Genet Metab 2000; 71:418-435.
23. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J. Stimulation of type I collagen transcription in human skin fibroblast by TGF-β: involvement of Smad 3. J Invest Dermatol 1999; 112:49-57. (Pubitemid 29024705)
24. Grande J, Melder D, Zinsmeister A, Killen P. Transforming growth factor-β1 induces collagen IV gene expression in NIH-3T3 cells. Lab Invest 1993; 69:387-395. (Pubitemid 2002944)
25. Grassel S, Tan EM, Timpl R, Chu ML. Collagen type XVI expression is modulated by basic fibroblast growth factor and transforming growth factor-β. FEBS Lett 1998; 436:197-201. (Pubitemid 28468555)
26. Varga J, Rosenbloom J, Jimenez SA. Transforming growth factor-β (TGF-β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblast. Biochem J 1987; 247:597-604.
27. Vindevoghel L, Lechleider RJ, Kon A, Caestecker MP, Uitto J, Roberts AB, Mauviel A. SMAD3/4-dependent transcriptional activation of the human type VII collagen (COL7A1) promoter by transforming growth factor-β. Proc Natl Acad Sci U S A 1998; 95:14769-14774. (Pubitemid 29003705)
28. Meurer SK, Tihaa L, Lahme B, Gressner AM, Weiskiichem R. Identification of endoglin in rat hepatic stellate cells: new insights into TGF-β receptor signaling. J Biol Chem 2005; 280:3078-3087.
29. Steffen K, Lahme B, Tihaa L, Weiskirchen R, Gressner AM. N-acetyl-L-Cysteine suppresses TGF-β signaling at distinct molecular steps: the biochemical and biological efficacy of a multifunctional, antifibrotic drug. Biochem Pharmacol 2005; 70:1026-1034. (Pubitemid 41262078)
30. Vendemiale G, Grattagliano I, Caruso ML, Servidio G, Valentini AM, Pirelli M, Altomare E. Increased oxidative stress in dimethylnitrosamine-induced liver fibrosisin the rat: effect of N-acetylcysteine and interferon-alpha. Toxicol Appl Pharmacol 2001; 175:130-139. (Pubitemid 32848504)
31. Horie T, Sakaida I, Yokoya F, Nakajo M, Sonaka I, Okita K. L-Cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activation. Biochem Biophys Res Commun 2003; 305:94-100. (Pubitemid 36535413)
32. Reyes-Gordillo K, Segovia J, Shibayama M, Vergara P, Moreno MG, Muriel P. Curcumin protects against acute liver damage in the rat by inhibiting NF-κB, proinflammatory cytokines production and oxidative stress. Biochim Biophys Acta 2007; 1770:989-996. (Pubitemid 46621136)
33. Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, et al. Evidence that reactive oxygen species do not mediate NF-κB activation. EMBO J 2003; 22:3356-3366. (Pubitemid 36834865)
34. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Ciccolo A, Centorrino T, et al. Protective effects of N-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat. FASEB J 2001; 15:1187-1200. (Pubitemid 32436304)
35. Geesin JC, Hendricks LJ, Falkenstein PA, Gordon JS, Berg RA. Regulation of collagen synthesis by ascorbic acid: characterization of the role of ascorbate-stimulated lipid peroxidation. Arch Biochem Biophys 1991; 290:127-132.
36. Svegliati Baroni G, D'ambrosio L, Ferreti G, Casini A, Di Sario A, Ridolfi R, et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998; 27:720-729.
37. Bedosa P, Houglum K, Trautwein C, Holstege A, Chojkier M. Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 1994; 19:1262-1271.
38. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995; 96:2461-2468.